In this digital transformation race sprung about by COVID-19, companies like IMAPAC have rapidly increased the use of digital tools to stay afloat during the pandemic. Revamping from having a portfolio that consisted… read more

In this digital transformation race sprung about by COVID-19, companies like IMAPAC have rapidly increased the use of digital tools to stay afloat during the pandemic. Revamping from having a portfolio that consisted… read more
INFOGRAPHIC OF THE WEEK In a recent market outlook analysis by Genetic Engineering & Biotechnology News, the APAC global cell and gene therapy space has been predicted to emerge as a major market.… read more
IMAPAC recently rounded up its “Corona360 In-Conversation” series of live moderated interviews. It brought together vaccine industry experts in lively, thought-provoking discussions on the challenges and possible solutions in the race to develop… read more
UCI Health Creates New Delivery System For Monoclonal Antibodies In COVID-19 Patients Samsung Bioepis Co., Ltd. announced the opening of its new headquarters in Korea’s ‘Bio Cluster’ of Songdo, located in the Incheon… read more
Biohaven's BHV-1200 Demonstrates Effective Neutralization Of COVID-19 Variants Samsung Bioepis Co., Ltd. announced the opening of its new headquarters in Korea’s ‘Bio Cluster’ of Songdo, located in the Incheon Free Economic Zone (IFEZ),… read more
Salk Scientists Reveals New Antibody Binding, Informing Liver Cancer, Antibody Design Samsung Bioepis Co., Ltd. announced the opening of its new headquarters in Korea’s ‘Bio Cluster’ of Songdo, located in the Incheon Free… read more
Moderna Therapeutics Expands Pipeline of Innovative mRNA-based Vaccines to Target HIV, Nipah Virus and More Moderna recently announced that it’ll continue to pursue advancement programs around three new vaccine candidates in 2021. These… read more
Moderna Therapeutics Expands Pipeline of Innovative mRNA-based Vaccines to Target HIV, Nipah Virus and More Moderna recently announced that it’ll continue to pursue advancement programs around three new vaccine candidates in 2021. These… read more
A Step Closer to Developing 'Smart' Stem Cells Made From Human Fat The scientists at University of New South Wales created iMS cells in a lab by exposing human fat cells to a… read more
Exelixis and Adagene Enter into Agreement to Develop Novel Masked Antibody-Drug Conjugate Therapies Samsung Bioepis Co., Ltd. announced the opening of its new headquarters in Korea’s ‘Bio Cluster’ of Songdo, located in the… read more
Samsung Bioepis Opens the New State-of-the-Art Headquarters to Accommodate Next Stage of Growth and Innovation Samsung Bioepis Co., Ltd. announced the opening of its new headquarters in Korea’s ‘Bio Cluster’ of Songdo, located… read more
Moderna Therapeutics Expands Pipeline of Innovative mRNA-based Vaccines to Target HIV, Nipah Virus and More Moderna recently announced that it’ll continue to pursue advancement programs around three new vaccine candidates in 2021. These… read more
A Step Closer to Developing 'Smart' Stem Cells Made From Human Fat The scientists at University of New South Wales created iMS cells in a lab by exposing human fat cells to a… read more